Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LILYANA AMEZCUA

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1306031240
CMS profile
104611
Location
LOS ANGELES, CA

General Payments · PY2018–2024

$201,861.53

  • Reported across 302 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$6,392.95

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $5,033.00 4
Food and Beverage $1,244.23 24
Education $115.72 10

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
EMD Serono, Inc. $2,724.69 6
Genentech, Inc. $1,532.80 2
TG THERAPEUTICS, INC. $1,377.44 8
NOVARTIS PHARMACEUTICALS CORPORATION $242.59 3
Amgen Inc. $186.48 12
Alexion Pharmaceuticals, Inc. $170.61 3
Genentech USA, Inc. $50.09 1
Biogen, Inc. $39.07 1
GENZYME CORPORATION $36.57 1
Celgene Corporation $32.61 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $22,857.18 35
PY2019 $55,507.43 74
PY2020 $33,686.48 24
PY2021 $17,567.64 20
PY2022 $22,873.78 42
PY2023 $42,976.07 69
PY2024 $6,392.95 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $30.02 05/13/2024 Food and Beverage Undisputed 01/23/2026 1094021383 CMS
Alexion Pharmaceuticals, Inc. $106.00 05/21/2024 Food and Beverage Undisputed 01/23/2026 1093986743 CMS
Alexion Pharmaceuticals, Inc. $34.59 09/18/2024 Food and Beverage Undisputed 01/23/2026 1093896116 CMS
Amgen Inc. $11.41 02/01/2024 Education Undisputed 01/23/2026 1111516315 CMS
Amgen Inc. $11.41 02/05/2024 Education Undisputed 01/23/2026 1111516317 CMS
Amgen Inc. $37.98 02/26/2024 Food and Beverage Undisputed 01/23/2026 1111516313 CMS
Amgen Inc. $13.11 02/26/2024 Education Undisputed 01/23/2026 1111516321 CMS
Amgen Inc. $11.41 03/14/2024 Education Undisputed 01/23/2026 1111516319 CMS
Amgen Inc. $13.11 04/22/2024 Education Undisputed 01/23/2026 1111516323 CMS
Amgen Inc. $10.52 05/06/2024 Education Undisputed 01/23/2026 1111516325 CMS
Amgen Inc. $10.52 05/20/2024 Education Undisputed 01/23/2026 1111516327 CMS
Amgen Inc. $32.78 05/20/2024 Food and Beverage Undisputed 01/23/2026 1111516329 CMS
Amgen Inc. $11.41 07/24/2024 Education Undisputed 01/23/2026 1111516333 CMS
Amgen Inc. $11.41 07/29/2024 Education Undisputed 01/23/2026 1111516331 CMS
Amgen Inc. $11.41 09/19/2024 Education Undisputed 01/23/2026 1111516335 CMS
Biogen, Inc. $39.07 01/29/2024 Food and Beverage Undisputed 01/23/2026 1104877388 CMS
Celgene Corporation $32.61 03/04/2024 Food and Beverage Undisputed 01/23/2026 1101140484 CMS
EMD Serono, Inc. $3.76 03/15/2024 Food and Beverage Undisputed 01/23/2026 1120236822 CMS
EMD Serono, Inc. $17.02 03/24/2024 Food and Beverage Undisputed 01/23/2026 1120236824 CMS
EMD Serono, Inc. $123.44 04/14/2024 Food and Beverage Undisputed 01/23/2026 1120249673 CMS
EMD Serono, Inc. $840.00 05/07/2024 Consulting Fee Undisputed 01/23/2026 1120275304 CMS
EMD Serono, Inc. $1,680.00 06/17/2024 Consulting Fee Undisputed 01/23/2026 1120275312 CMS
EMD Serono, Inc. $60.47 12/03/2024 Food and Beverage Undisputed 01/23/2026 1120274456 CMS
Genentech USA, Inc. $50.09 04/15/2024 Food and Beverage Undisputed 01/23/2026 1133054307 CMS
Genentech, Inc. $32.80 02/12/2024 Food and Beverage Undisputed 01/23/2026 1133054311 CMS
Genentech, Inc. $1,500.00 08/29/2024 Consulting Fee Undisputed 01/23/2026 1133054315 CMS
GENZYME CORPORATION $36.57 04/08/2024 Food and Beverage Undisputed 01/23/2026 1139764728 CMS
Novartis Pharmaceuticals Corporation $28.20 04/22/2024 Food and Beverage Undisputed 01/23/2026 1086656603 CMS
Novartis Pharmaceuticals Corporation $118.15 05/16/2024 Food and Beverage Undisputed 01/23/2026 1086656597 CMS
Novartis Pharmaceuticals Corporation $96.24 07/10/2024 Food and Beverage Undisputed 01/23/2026 1086656595 CMS
TG Therapeutics, Inc. $50.62 04/11/2024 Food and Beverage Undisputed 01/23/2026 1136891728 CMS
TG Therapeutics, Inc. $1,013.00 04/12/2024 Consulting Fee Undisputed 01/23/2026 1136891750 CMS
TG Therapeutics, Inc. $120.73 04/12/2024 Food and Beverage Undisputed 01/23/2026 1136891768 CMS
TG Therapeutics, Inc. $35.87 05/06/2024 Food and Beverage Undisputed 01/23/2026 1136891672 CMS
TG Therapeutics, Inc. $33.90 05/10/2024 Food and Beverage Undisputed 01/23/2026 1136891650 CMS
TG Therapeutics, Inc. $23.35 07/22/2024 Food and Beverage Undisputed 01/23/2026 1136891718 CMS
TG Therapeutics, Inc. $74.25 09/18/2024 Food and Beverage Undisputed 01/23/2026 1136891702 CMS
TG Therapeutics, Inc. $25.72 10/21/2024 Food and Beverage Undisputed 01/23/2026 1136891804 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.